−0.027SEK
−7.83 MSEK
234.67 M
About RESPIRATORIUS AB
Sector
CEO
Johan Drott
Headquarters
Lund
Website
Founded
1998
ISIN
SE0004550192
FIGI
BBG002ZKK3S3
Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RESP is 0.277 SEK — it has increased by 1.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange RESPIRATORIUS AB stocks are traded under the ticker RESP.
RESP stock is 8.85% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is RESPIRATORIUS AB there?
Yes, you can track RESPIRATORIUS AB financials in yearly and quarterly reports right on TradingView.
RESP stock has fallen by 22.19% compared to the previous week, the month change is a 21.49% rise, over the last year RESPIRATORIUS AB has showed a 28.97% decrease.
RESP net income for the last quarter is −2.45 M SEK, while the quarter before that showed −1.28 M SEK of net income which accounts for −91.34% change. Track more RESPIRATORIUS AB financial stats to get the full picture.
Today RESPIRATORIUS AB has the market capitalization of 80.09 M, it has increased by 78.77% over the last week.
No, RESP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RESP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESPIRATORIUS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESPIRATORIUS AB technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESPIRATORIUS AB stock shows the neutral signal. See more of RESPIRATORIUS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.